A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/133 (2006.01) A61K 31/00 (2006.01) A61K 31/135 (2006.01) A61K 45/06 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2545503
Disclosed is the use of sphingosine-1-phosphate (S1P) receptor agonists, preferably 2-amino-2- [2- (4-octylphenyl)ethyl] propane-1,3-diol, in the treatment of progressive dementia or brain degenerative diseases.
L'invention concerne l'utilisation d'agonistes vis-à-vis du récepteur de sphingosine-1-phosphate (S1P) pour le traitement de la démence progressive ou des maladies cérébrales dégénératives.
Brinkmann Volker
Kaneider Nicole
Wiedermann Christian J.
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Use of sphingosine-1-phosphate (s1p) receptor agonists for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of sphingosine-1-phosphate (s1p) receptor agonists for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sphingosine-1-phosphate (s1p) receptor agonists for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1521430